Idiopathic Hypoparathyroidism Presenting As New Onset Refractory Status Epilepticus
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Idiopathic Hypoparathyroidism Presenting As New Onset Refractory Status Epilepticus ; volume:12 ; number:04 ; year:2021 ; pages:796-797
Journal of neurosciences in rural practice ; 12, Heft 04 (2021), 796-797
- Contributor
-
Gomathy, Saranya B.
Radhakrishnan, Divya M.
Das, Animesh
Srivastava, Achal K.
- DOI
-
10.1055/s-0041-1735247
- URN
-
urn:nbn:de:101:1-2021121610443646850477
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gomathy, Saranya B.
- Radhakrishnan, Divya M.
- Das, Animesh
- Srivastava, Achal K.
Other Objects (12)
Cytokines in new-onset refractory status epilepticus: ready for clinical use?
Long-term outcome in new onset refractory status epilepticus: a retrospective study
Early clinical features of new-onset refractory status epilepticus (NORSE) in adults
Overview of new-onset refractory status epilepticus: current concepts, diagnosis, and management
A favorable outcome of intensive immunotherapies for new-onset refractory status epilepticus (NORSE)
Current Trends in Treatment of Status Epilepticus and Refractory Status Epilepticus
Intravenous immunoglobulin response in new-onset refractory status epilepticus (NORSE) COVID-19 adult patients
Epilepsy surgery in pediatric refractory status epilepticus
Functional outcome of prolonged refractory status epilepticus
The Treatment and Prognosis of Refractory and Super-Refractory Status Epilepticus
Stiripentol for the treatment of refractory status epilepticus
(S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study
Cytokines in new-onset refractory status epilepticus: ready for clinical use?
Long-term outcome in new onset refractory status epilepticus: a retrospective study
Early clinical features of new-onset refractory status epilepticus (NORSE) in adults
Overview of new-onset refractory status epilepticus: current concepts, diagnosis, and management
A favorable outcome of intensive immunotherapies for new-onset refractory status epilepticus (NORSE)
Current Trends in Treatment of Status Epilepticus and Refractory Status Epilepticus
Intravenous immunoglobulin response in new-onset refractory status epilepticus (NORSE) COVID-19 adult patients
Epilepsy surgery in pediatric refractory status epilepticus
Functional outcome of prolonged refractory status epilepticus
The Treatment and Prognosis of Refractory and Super-Refractory Status Epilepticus
Stiripentol for the treatment of refractory status epilepticus
(S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study
Cytokines in new-onset refractory status epilepticus: ready for clinical use?
Long-term outcome in new onset refractory status epilepticus: a retrospective study
Early clinical features of new-onset refractory status epilepticus (NORSE) in adults
Overview of new-onset refractory status epilepticus: current concepts, diagnosis, and management
A favorable outcome of intensive immunotherapies for new-onset refractory status epilepticus (NORSE)
Current Trends in Treatment of Status Epilepticus and Refractory Status Epilepticus
Intravenous immunoglobulin response in new-onset refractory status epilepticus (NORSE) COVID-19 adult patients
Epilepsy surgery in pediatric refractory status epilepticus
Functional outcome of prolonged refractory status epilepticus
The Treatment and Prognosis of Refractory and Super-Refractory Status Epilepticus
Stiripentol for the treatment of refractory status epilepticus